Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1958 1
1962 1
1963 1
1966 1
1967 1
1969 2
1973 2
1998 1
1999 1
2001 1
2002 2
2003 1
2004 4
2005 5
2006 2
2007 1
2008 3
2009 2
2010 2
2012 1
2014 2
2015 1
2016 1
2017 1
2018 1
2020 2
2021 4
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial.
Rizvi NA, Cho BC, Reinmuth N, Lee KH, Luft A, Ahn MJ, van den Heuvel MM, Cobo M, Vicente D, Smolin A, Moiseyenko V, Antonia SJ, Le Moulec S, Robinet G, Natale R, Schneider J, Shepherd FA, Geater SL, Garon EB, Kim ES, Goldberg SB, Nakagawa K, Raja R, Higgs BW, Boothman AM, Zhao L, Scheuring U, Stockman PK, Chand VK, Peters S; MYSTIC Investigators. Rizvi NA, et al. Among authors: smolin a. JAMA Oncol. 2020 May 1;6(5):661-674. doi: 10.1001/jamaoncol.2020.0237. JAMA Oncol. 2020. PMID: 32271377 Free PMC article. Clinical Trial.
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide.
Liu SV, Mok TSK, Nabet BY, Mansfield AS, De Boer R, Losonczy G, Sugawara S, Dziadziuszko R, Krzakowski M, Smolin A, Hochmair MJ, Garassino MC, Gay CM, Heymach JV, Byers LA, Lam S, Cardona A, Morris S, Adler L, Shames DS, Reck M. Liu SV, et al. Among authors: smolin a. Lung Cancer. 2023 Dec;186:107418. doi: 10.1016/j.lungcan.2023.107418. Epub 2023 Oct 31. Lung Cancer. 2023. PMID: 37931445 Free article. Clinical Trial.
Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide.
Reck M, Mok TSK, Mansfield A, De Boer R, Losonczy G, Sugawara S, Dziadziuszko R, Krzakowski M, Smolin A, Hochmair M, Garassino MC, de Castro Junior G, Bischoff H, Lam S, Cardona A, Morris S, Liu SV. Reck M, et al. Among authors: smolin a. J Thorac Oncol. 2022 Sep;17(9):1122-1129. doi: 10.1016/j.jtho.2022.05.016. Epub 2022 Jun 25. J Thorac Oncol. 2022. PMID: 35764236 Free article. Clinical Trial.
Numerical Modeling of Shockwave Treatment of Knee Joint.
Eremina G, Smolin A. Eremina G, et al. Among authors: smolin a. Materials (Basel). 2021 Dec 13;14(24):7678. doi: 10.3390/ma14247678. Materials (Basel). 2021. PMID: 34947273 Free PMC article.
Treatment of patients with brain metastases.
Golanov AV, Banov SM, Il'yalov SR, Vetlova ER, Smolin AV, Bekyashev AK, Dolgushin MB, Naskhletashvili DR, Nazarenko AV, Medvedev SV. Golanov AV, et al. Among authors: smolin av. Zh Vopr Neirokhir Im N N Burdenko. 2016;80(4):89-101. doi: 10.17116/neiro201680489-100. Zh Vopr Neirokhir Im N N Burdenko. 2016. PMID: 27500778 Free article. English, Russian. No abstract available.
55 results